The 2025 GOLD COPD report has a new emphasis on CV disease and PH in COPD and major updates on new drugs, climate change, and ...

Postpartum diabetes risk was elevated among women with a history of gestational diabetes and a high-stable or inverse U-shaped BMI trajectory.

Lithium aspartate does not provide significant relief for post-COVID-19 symptoms of fatigue or cognitive dysfunction.

Using single maintenance and reliever therapy (SMART) is cost‐effective vs ICS/LABA maintenance plus SABA reliever in uncontrolled asthma.

Topline results were announced from a phase 3 trial evaluating SC pembrolizumab with berahyaluronidase alfa in metastatic NSCLC.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

In IPF, antifibrotic therapy discontinuation was linked to patient variables that included depression, lower DLCO, and higher all-cause mortality.

Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and diabetes.

Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023.

Compared to DNA sequencing alone, concurrent DNA and RNA sequencing revealed more clinically actionable variants in NSCLC.

Casirivimab and imdevimab in combination is safe among pediatric outpatients with at least 1 risk factor for severe COVID-19.

Povidone-iodine vs chlorohexidine gluconate demonstrated a reduction in deep SSI, but an increased risk for overall and superficial SSI.